AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Omizra ES D 30mg/40mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Astrica Biomedics Pvt Ltd

Salt Composition

Domperidone (30mg) + Esomeprazole (40mg)

Overview Omizra ES D 30mg/40mg Capsule SR

Gastroesophageal reflux disease (GERD) and indigestion symptoms, such as heartburn, stomach upset, and irritation, are addressed by the prescription medication Omizra ES D 30mg/40mg sustained-release capsules. This medication works by neutralizing stomach acid and facilitating gas expulsion to alleviate discomfort. As directed by your physician, take Omizra ES D 30mg/40mg SR capsules on an empty stomach. Dosage depends on your individual response and condition; continue treatment for the prescribed duration. Premature discontinuation may lead to symptom recurrence and condition worsening. Inform your doctor about all other medications you are using, as interactions may occur. Common, generally transient side effects include diarrhea, gas, abdominal pain, dry mouth, and headache. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, may enhance treatment outcomes. Consult your doctor before use if pregnant, planning pregnancy, breastfeeding, or if you have liver disease; appropriate dosage adjustments may be necessary.

Uses of Omizra ES D 30mg/40mg Capsule SR

Managing gastroesophageal reflux disease (GERD)

Major Benefits of Omizra ES D 30mg/40mg Capsule SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Omizra ES D 30mg/40mg Capsule SR whole; do not crush, chew, or divide it. Administer on an empty stomach.

Common Side effects of Omizra ES D 30mg/40mg Capsule SR:

  • Diarrhea
  • Flatulence
  • Stomach pain
  • Dryness in mouth
  • Headache
  • Fundic gland polyps

How to use Omizra ES D 30mg/40mg Capsule SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Omizra ES D 30mg/40mg Capsule SR. Ingest the capsule whole; do not fracture, pulverize, or chew it. Administer on an empty stomach.

How Omizra ES D 30mg/40mg Capsule SR works:

Omizra ES D 30mg/40mg sustained-release capsules contain Domperidone and Esomeprazole. Domperidone, a gastrointestinal motility stimulant, enhances upper digestive tract movement, facilitating food passage. Esomeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from acid indigestion and heartburn symptoms.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Omizra ES D 30mg/40mg Capsule SR with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Omizra ES D 30mg/40mg SR Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The extended-release capsule Omizra ES D, containing 30mg/40mg, presents no known breastfeeding risks. Research in humans indicates minimal drug transfer to breast milk, posing no discernible threat to the infant.

DrivingDrivingUNSAFE

Driving should be avoided if you experience drowsiness, dizziness, or visual disturbances after taking Omizra ES D 30mg/40mg SR Capsules, as these may impair alertness.

KidneyKidneyCAUTION

Renal impairment necessitates careful administration of Omizra ES D 30mg/40mg sustained-release capsules. Dosage modification may be required. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Omizra ES D 30mg/40mg SR capsules cautiously, as dosage modification may be necessary. Consult a physician for guidance. Omizra ES D 30mg/40mg SR capsules are contraindicated for individuals with moderate to severe hepatic dysfunction.

What if you forget to take Omizra ES D 30mg/40mg Capsule SR :

Should you forget a dose of Omizra ES D 30mg/40mg SR Capsules, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Omizra ES D 30mg/40mg Capsule SR

LabelValue
Potential for Dependence None.
Type of Treatment Digestive system

FAQs on Omizra ES D 30mg/40mg Capsule SR

Omizra ES D 30mg/40mg sustained-release capsules contain domperidone and esomeprazole. This dual-drug formulation addresses heartburn, acid reflux (GERD—gastroesophageal reflux disease), where stomach acid enters the esophagus, and also manages gastric and duodenal ulcers. Domperidone's action facilitates improved gut motility, easing food passage through the stomach and thereby mitigating nausea and vomiting.
Omizra ES D 30mg/40mg sustained-release capsules are generally well-tolerated. Nevertheless, some individuals may experience side effects such as diarrhea, abdominal pain, gas, dry mouth, vertigo, or headache. Less frequent or rare adverse reactions are also possible. Report any ongoing issues to your physician during treatment.
For optimal absorption, consume Omizra ES D 30mg/40mg sustained-release capsules before your initial meal or while fasting.
Taking Omizra ES D 30mg/40mg Capsule SR may raise the likelihood of developing a serious irregular heartbeat. While this is a significant potential adverse reaction, the probability of occurrence is quite small. However, individuals over 60 might face a marginally increased risk.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any other excipient in Omizra ES D 30mg/40mg Capsule SR should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring while taking this medication.
Indeed, Omizra ES D 30mg/40mg SR Capsules may induce xerostomia. This side effect is attributed to the domperidone component. To alleviate dry mouth, increase your fluid intake. Maintain consistent hydration throughout the day, including keeping water readily available overnight. Reduce alcohol consumption and refrain from smoking. For dry mouth, opt for alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a possible side effect of Omizra ES D 30mg/40mg SR Capsules. If diarrhea occurs, increase your fluid intake. Consult your physician if diarrhea continues or if you experience dehydration symptoms such as reduced urination and dark, concentrated urine. Dietary changes may be necessary, avoiding greasy or fried foods while taking this medication. Always seek medical advice before using any other medications concurrently.
Maintain this medication within its original, securely sealed container. Follow the storage guidelines specified on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Omizra ES D 30mg/40mg Cap...
90
MRP 110
18% off